Stage I Marginal Zone Lymphoma Terminated Phase 2 Trials for Fludarabine (DB01073)

IndicationStatusPhase
DBCOND0029479 (Stage I Marginal Zone Lymphoma)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01044745Rituximab in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic CancerTreatment